Medicines as a service : a new commercial model for big pharma in the postblockbuster world / / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu.
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
Saved in:
| Superior document: | RAND Health occasional paper |
|---|---|
| : | |
| TeilnehmendeR: | |
| Year of Publication: | 2012 |
| Edition: | 1st ed. |
| Language: | English |
| Series: | Occasional paper (Rand Corporation)
|
| Physical Description: | 1 online resource (12 p.) |
| Notes: | Description based upon print version of record. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. |
|---|---|
| Bibliography: | Includes bibliographical references. |
| ISBN: | 0833076469 |
| Hierarchical level: | Monograph |
| Statement of Responsibility: | Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |